Streetbeat News

Price Targets

BRZE

Canaccord Genuity analyst David Hynes maintains a Buy rating on Braze (NASDAQ:BRZE) but lowers the price target from $70 to $65.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:24 am

GNL

Truist Securities analyst Anthony Hau initiates coverage on Global Net Lease (GNL) with a Hold rating and sets a price target of $7.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:23 am

PSA

Raymond James analyst Jonathan Hughes upgraded Public Storage (NYSE:PSA) from Market Perform to Strong Buy and set a $330 price target.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:18 am

RH

Telsey Advisory Group analyst Joseph Feldman has maintained a 'Market Perform' rating on RH (NYSE:RH) and increased the price target from $285 to $335.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:16 am

SRRK

Raymond James analyst Gary Nachman initiates coverage on Scholar Rock Holding (NASDAQ:SRRK) with a Strong Buy rating and a price target of $30.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:16 am

M

Telsey Advisory Group analyst Dana Telsey maintains a Market Perform rating on Macy's (NYSE:M) and keeps the price target at $21.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:14 am

KR

Telsey Advisory Group analyst Joseph Feldman has maintained an Outperform rating on Kroger (NYSE:KR) and increased the price target from $60 to $62.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:13 am

XERS

Xeris Biopharma Holdings' stock price increased following Oppenheimer's initiation of coverage with an Outperform rating and a price target of $5.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:12 am

BRZE

Needham analyst Scott Berg has reiterated a Buy rating on Braze (NASDAQ:BRZE) and maintained a $70 price target.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:11 am

AQST

Raymond James analyst Gary Nachman initiates coverage on Aquestive Therapeutics (NASDAQ:AQST) with an Outperform rating and a price target of $7.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:10 am